Koyfin Home > Directory > Health Care > Portola Pharma > EV / EBITDA (ntm)

Portola Pharma EV / EBITDA (ntm) Chart (PTLA)

Portola Pharma annual/quarterly EV / EBITDA (ntm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Portola Pharma Market Cap for the quarter ending March 03, 2018 was $2,136m a -49.96% decrease of -1,067m year over year
  • Portola Pharma Price / Book for the quarter ending March 03, 2018 was 6.15 a -222.27% decrease of -13.67 year over year
  • Portola Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,780m a -67.70% decrease of -1,205m year over year
View Chart On Koyfin